PLAU and cancer: As a natural inhibitor of urokinase-type plasminogen activator (u-PA) and tissue-type plasminogen activator (t-PA)—two molecules commonly associated with angiogenesis, metastasis and cancer progression—it was expected that PAI-1 would successfully prevent the development of cancers.